NEW YORK, Jan. 6, 2020 /PRNewswire/ --
Global Recombinant Cell Culture Supplements Market to Reach $977.8 Million by 2029
Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN
Key Questions Answered in this Report: What is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications? What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope? What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market? What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies? What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products? What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029? What are the different recombinant supplement products involved in cell culture? Which product type dominate the market in 2018 and why? Which product type are expected to witness highest growth rate and to dominate in market in 2029? What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029? What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market? Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market? What are the key players of the global recombinant cell culture supplements market and what is their role in the market?
Global Recombinant Cell Culture Supplements Market Forecast, 2019-2029 The recombinant cell culture supplements market analysis projects the market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029. The recombinant cell culture supplements market generated $258.8 million revenue in 2018, in terms of value. The recombinant cell culture supplements market growth has been primarily attributed to the major drivers in this market such as advantages offered by recombinant cell culture supplements and the promising impact displayed by them in culturing cells act as drivers for the growth of the market.Moreover, an increase in funding and investment supporting the advancement of life-science research with an ever-increasing demand for advanced cell culture systems have boosted the adoption rate of recombinant cell-culture supplements products. However, there are significant challenges which are restraining the market growth.These challenges include the shortage of skilled professionals and lack of proper laboratory infrastructure. Further, high cost of the cell culturing process and complications involved in it are also acting as challenge for the market. Expert Quote "The most important advantage of utilizing these recombinant proteins is that they facilitate large batch biomanufacturing with minimal risk of contamination and improved adhesion. Another advantage is that it involves animal-free manufacturing which in turn simplifies regulatory issues and export-import issues." Scope of the Market Intelligence on Recombinant Cell Culture Supplements Market The recombinant cell culture supplements market report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements. The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market. Market Segmentation The recombinant cell culture supplements market segmentation (on the basis of product) is further segmented into recombinant insulin, transferrin, albumin, among others. The recombinant cell culture supplements market segmentation (on the basis of application) is segmented into stem cell and regenerative medicine, bio-production, and academic and research. The recombinant cell culture supplements market segmentation (on the basis of region) is segmented into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World. Key Companies in the Recombinant Cell Culture Supplements Market The key manufacturers who have been contributing significantly to the Recombinant Cell Culture Supplements Market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others. Countries Covered North America U.S. Canada Europe Germany France U.K. Italy Spain The Netherlands Rest-of-Europe Asia-Pacific China Japan South Korea India Australia Rest-of-Asia-Pacific Latin America Brazil Mexico Rest-of-Latin America Rest-of-the-World Russia Israel Kingdom of Saudi Arabia (K.S.A.)
Read the full report: https://www.reportlinker.com/p05835676/?utm_source=PRN
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
SOURCE Reportlinker
Read more:
- Asymmetrex Presents the Impact of Differential Stem Cell Counting for Cultured Meat Production - EIN News - October 30th, 2024
- Minor cannabinoid shows promise in reducing anxiety - Drug Discovery News - October 30th, 2024
- Experts call for clear and concise regulation of exosome-based treatments - Medical Xpress - October 27th, 2024
- Stem cells: Arthritic vulture reunited with partner after jab - BBC.com - October 25th, 2024
- Cholesterol medications might be able to be repurposed for MS: Study - Multiple Sclerosis News Today - October 25th, 2024
- Cell and Gene Therapies Symposium Open to Public | Newswise - Newswise - October 25th, 2024
- Could This Protein Hold the Key to Reversing Brain Aging and Repairing Damage? - SciTechDaily - October 24th, 2024
- Arthritic vulture Bernard has his knee fixed in stem cell first - BBC.com - October 24th, 2024
- Findings in fruit flies could lead to new Parkinsons stem cell therapies - Parkinson's News Today - October 24th, 2024
- Stem Cell Therapy Market Size to Hit USD 48.89 Billion by 2033 - GlobeNewswire - October 22nd, 2024
- Japan mulls ways to boost cell, gene therapy approvals - BioWorld Online - October 22nd, 2024
- Meso Numismatics Changes Name to Regenerative Medical Technology Group and Ticker Symbol to RMTG - Newswire - October 22nd, 2024
- Medeze Group Awarded Frost & Sullivan's 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions... - October 20th, 2024
- MexStemCells Clinic Partners with PlacidWay Medical Tourism to Expand Global Access to Regenerative Medicine - EIN News - October 20th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - The Conversation - October 18th, 2024
- Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology,... - October 18th, 2024
- Healing begins with research: Promising development program on stem cells in rare diseases - Pharmaceutical Technology - October 15th, 2024
- Chuck Murry | Stem cell science for healing the heart - University of Southern California - October 15th, 2024
- Stem cell therapy reverses type 1 diabetes in world first - Medical Xpress - October 15th, 2024
- AI Scaling Laws Poised To Transform Cell Replacement Therapy - Forbes - October 15th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 15th, 2024
- Stem cell discovery highlights importance of DNA methylation in cancer - Medical Xpress - October 11th, 2024
- $8.1M Grant Will Allow Researchers to Study the Ro | Newswise - Newswise - October 11th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 10th, 2024
- Improving Access to Cell and Gene Therapy in Pedia | Newswise - Newswise - October 10th, 2024
- Osteopore Partners with RxCell for Regenerative Medicine - TipRanks - October 10th, 2024
- USC's Keck School of Medicine partners with StemCardia to advance heart failure treatment - News-Medical.Net - October 10th, 2024
- Dr. Abdul Baker Pioneers Robotic Surgery and Stem Cell Therapy for Innovative Treatment & Recovery - openPR - October 8th, 2024
- How a Court Ruling Affects California Stem Cell Clinics That Use Unproven Therapies - KQED - October 8th, 2024
- Stem-cell therapy reverses type 1 diabetes in groundbreaking case study - Medical News Today - October 4th, 2024
- Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in... - October 4th, 2024
- Stem cell therapy to cure T1 diabetes? The Indian perspective - The Hindu - October 4th, 2024
- Stem cell therapy for osteoarthritis: Functional cartilage regeneration using 3d bioprinting technology - Open Access Government - October 4th, 2024
- Innovative Opportunities in Stem Cell Treatments: Insights from Genoma - Medical Tourism Magazine - October 4th, 2024
- BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - Yahoo Finance - October 4th, 2024
- Palmetto Stem Cell Therapy Advises on Streamlining the Regenerative Medicine Process for Joint Pain Relief - The Globe and Mail - October 2nd, 2024
- Woman's Own Stem Cells Appear to Reverse Her Type 1 Diabetes in First-Ever Procedure - Futurism - October 2nd, 2024
- Cell & Co. is Revolutionizing Regenerative Healthcare with Cutting-Edge Stem Cell Therapy in Malaysia - openPR - October 2nd, 2024
- Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience - MSN - October 2nd, 2024
- What are Exosomes, Growth Factors and Stem Cells? - NewBeauty Magazine - September 30th, 2024
- Treatment - National Heart, Lung, and Blood Institute - September 30th, 2024
- Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience - Medical Xpress - September 30th, 2024
- Stem Cell Therapy Market Overview, Share Analysis, Size And Forecast To 2033 - WhaTech - September 30th, 2024
- StemCardia Licenses Technologies for Heart Regeneration Developed at UW School of Medicine - Business Wire - September 30th, 2024
- Chinese Woman Becomes First In The World To Be Cured Of Type 1 Diabetes With Stem Cell Transplant - GreekCityTimes.com - September 30th, 2024
- Following Their Calling to Help Young Cancer Patients and Beyond - Stanford Children's Health - September 28th, 2024
- Greenberg Regenerative Medicine Celebrates Nearing 2 Years of Success with Pioneering VSEL Therapy - PR.com - September 28th, 2024
- Discovery clears hurdle in growing organs for transplants : Newsroom - UT Southwestern - September 26th, 2024
- Cell Therapy Market is Expected to Gain USD 60696.42 Million with a Growing CAGR of 19.20% by 2030 - openPR - September 25th, 2024
- Stem Cell Therapy Market To Reach USD 44 Billion By 2032 (Updated 2024) - Market.us Media - United States Market News - September 25th, 2024
- Doctors cured her sickle-cell disease. So why is she still in pain? - Nature.com - September 23rd, 2024
- The new frontier of luxury travel is a $44,000 course of stem cells and a longevity club stocked with IV stations - Fortune - September 23rd, 2024
- How stem cell and gene therapies are revolutionising healthcare - Express Healthcare - September 20th, 2024
- Exploring Regenerative Medicine and Its Impact on Modern Disease Management - Baltimore Post-Examiner - September 18th, 2024
- Stem Cell Therapy Market Dynamics: Size, Share, and Growth - openPR - September 16th, 2024
- Stem Cell Restore Review: Can It Boost Your Stem Cell Activity for Lasting Health? - Vashon-Maury Island Beachcomber - September 14th, 2024
- Stem Cell Therapy Market valued at USD 3.40 Billion by 2030 As Revealed In New Report - WhaTech - September 14th, 2024
- Stem Cell Manufacturing Market Projected to Witness Huge Growth by 2024-2031 As Revealed In New Report - WhaTech - September 14th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 12th, 2024
- Meso Numismatics Announces Cellgenics Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September - StockTitan - September 10th, 2024
- Meso Numismatics Announces Cellgenics Sponsorship of Three Prominent Regenerative Medicine Events in Peru This September - Newswire - September 10th, 2024
- Breakthrough in blood stem cell development offers hope for leukemia and bone marrow failure - News-Medical.Net - September 8th, 2024
- Stem Cell Therapy Market Is Estimated To Reach $928.6 Million by 2031 | CAGR 16.2% - EIN News - September 8th, 2024
- USC researchers receive funding to develop next generation of intelligent biocomputers - EurekAlert - September 8th, 2024
- Risk Factors and Indications for Stem Cell Transplants in MDS - Targeted Oncology - September 6th, 2024
- Cell Therapy Market Size to Hit USD 28.98 Billion by 2032, - GlobeNewswire - September 6th, 2024
- Blood stem cells grown in the lab for the first time ever - Earth.com - September 6th, 2024
- Top 3 Grants in Regenerative Medicine: August 2024 - RegMedNet - September 6th, 2024
- New approach moves cell therapy closer to treating many disorders - Medical Xpress - September 4th, 2024
- Stem Cell Therapy Mexico: R3 Stem Cell Unveils Innovative and Affordable Non-Invasive Solutions - openPR - September 4th, 2024
- What Sets Immunotherapy Regenerative Medicine Apart in a Crowded Regenerative Market? - Flaunt Magazine - September 2nd, 2024
- Tiny Test Tubes Sort Stem Cells for Improved Therapy - The Scientist - August 31st, 2024
- Dr. Crandall: Stem Cell Treatment Heals the Heart - Newsmax - August 31st, 2024
- From stem cells to technology, the next Wisconsin RISE initiative focuses on improving health - University of Wisconsin-Madison - August 29th, 2024
- aHSCT Stem Cell Therapy for MS | National MS Society - National MS Society - August 29th, 2024
- Are Stem Cells the Secret to Anti-Aging? - The Edge - August 22nd, 2024
- A Comprehensive Review of the Role of Stem Cells in Neuroregeneration: Potential Therapies for Neurological Disorders - Cureus - August 22nd, 2024
- Scientists discover method to activate dormant stem cells in the brain - Medical Xpress - August 20th, 2024
- New way to extend 'shelf life' of blood stem cells can improve gene therapy - Medical Xpress - August 20th, 2024
- Where Are the Cell Therapies for Type 1 Diabetes? - Inside Precision Medicine - August 14th, 2024
Recent Comments